Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HALDER VENTURE LIMITED vs BALAXI PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HALDER VENTURE LIMITED BALAXI PHARMA HALDER VENTURE LIMITED/
BALAXI PHARMA
 
P/E (TTM) x 37.7 12.3 306.4% View Chart
P/BV x 4.8 2.2 216.4% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 HALDER VENTURE LIMITED   BALAXI PHARMA
EQUITY SHARE DATA
    HALDER VENTURE LIMITED
Mar-24
BALAXI PHARMA
Mar-24
HALDER VENTURE LIMITED/
BALAXI PHARMA
5-Yr Chart
Click to enlarge
High Rs372686 54.2%   
Low Rs214400 53.6%   
Sales per share (Unadj.) Rs2,036.9221.4 920.1%  
Earnings per share (Unadj.) Rs36.9-2.2 -1,686.0%  
Cash flow per share (Unadj.) Rs52.7-0.3 -19,859.5%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.30-  
Book value per share (Unadj.) Rs187.8181.3 103.6%  
Shares outstanding (eoy) m3.1610.90 29.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.12.5 5.9%   
Avg P/E ratio x7.9-248.0 -3.2%  
P/CF ratio (eoy) x5.6-2,051.6 -0.3%  
Price / Book Value ratio x1.63.0 52.1%  
Dividend payout %2.70-   
Avg Mkt Cap Rs m9275,919 15.7%   
No. of employees `000NANA-   
Total wages/salary Rs m105280 37.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,4372,413 266.8%  
Other income Rs m736 1,146.4%   
Total revenues Rs m6,5092,419 269.1%   
Gross profit Rs m34262 547.5%  
Depreciation Rs m5021 237.0%   
Interest Rs m19328 696.3%   
Profit before tax Rs m17220 855.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5644 126.4%   
Profit after tax Rs m117-24 -488.8%  
Gross profit margin %5.32.6 205.3%  
Effective tax rate %32.3218.5 14.8%   
Net profit margin %1.8-1.0 -183.2%  
BALANCE SHEET DATA
Current assets Rs m3,7102,102 176.5%   
Current liabilities Rs m2,939542 542.2%   
Net working cap to sales %12.064.6 18.5%  
Current ratio x1.33.9 32.6%  
Inventory Days Days128 164.5%  
Debtors Days Days1,074843 127.5%  
Net fixed assets Rs m727482 150.9%   
Share capital Rs m32109 29.0%   
"Free" reserves Rs m5621,867 30.1%   
Net worth Rs m5931,976 30.0%   
Long term debt Rs m1100-   
Total assets Rs m4,4372,583 171.7%  
Interest coverage x1.91.7 109.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.50.9 155.3%   
Return on assets %7.00.1 4,747.8%  
Return on equity %19.7-1.2 -1,627.6%  
Return on capital %51.92.4 2,142.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m114648 17.6%   
Fx outflow Rs m2,83719 15,108.3%   
Net fx Rs m-2,723629 -432.8%   
CASH FLOW
From Operations Rs m-1949 -38.1%  
From Investments Rs m-193-10 1,848.9%  
From Financial Activity Rs m262303 86.6%  
Net Cashflow Rs m50341 14.7%  

Share Holding

Indian Promoters % 65.7 66.0 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 16.5 -  
FIIs % 0.0 16.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 34.3 34.0 100.9%  
Shareholders   1,351 7,863 17.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HALDER VENTURE LIMITED With:   ADANI ENTERPRISES    REDINGTON    MMTC    SIRCA PAINTS INDIA    MSTC    


More on HALDER VENTURE LIMITED vs BALAXI PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

HALDER VENTURE LIMITED vs BALAXI PHARMA Share Price Performance

Period HALDER VENTURE LIMITED BALAXI PHARMA
1-Day 0.36% 2.34%
1-Month 18.01% -9.87%
1-Year 201.96% -81.85%
3-Year CAGR 10.24% -49.68%
5-Year CAGR 78.01% -33.77%

* Compound Annual Growth Rate

Here are more details on the HALDER VENTURE LIMITED share price and the BALAXI PHARMA share price.

Moving on to shareholding structures...

The promoters of HALDER VENTURE LIMITED hold a 65.7% stake in the company. In case of BALAXI PHARMA the stake stands at 66.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of HALDER VENTURE LIMITED and the shareholding pattern of BALAXI PHARMA.

Finally, a word on dividends...

In the most recent financial year, HALDER VENTURE LIMITED paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 2.7%.

BALAXI PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of HALDER VENTURE LIMITED, and the dividend history of BALAXI PHARMA.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.